Tianda Pharmaceuticals Limited ("Tianda Pharmaceuticals", listed on the Hong Kong Stock Exchange, stock code: 0455) implements the following development strategies: development of Traditional Chinese medicine ("TCM") as its foundation, development of innovative drugs and medical technologies, as well as development of high-quality medical and healthcare services.
It is committed to becoming a competitive pharmaceutical enterprise and core value chain in pharmaceuticals, medical technology, TCM treatment and health management.
Investor Relations Manager Responsibilities: Organize and manage investor relations activities including annual general meetings, roadshows, press conferences, and analyst briefings; Monitor the company's stock performance and valuation metrics regularly, and analyze factors affecting market capitalization, including investor sentiment, peer performance, and macroeconomic trends; Engage investors, analysts, and funds; coordinate meetings and roadshows; Propose compliant initiatives to improve market understanding and valuation; Identify and approach potential investors and strategic capital sources; Prepare investor presentations and support results announcement and briefings; and ensure all materials are aligned with corporate strategy, financial performance, and regulatory requirements.
